# Bauhinia forficata (Pata de Vaca)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bauhinia-forficata
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** Pata de Vaca, Cow's Hoof, Cow's Foot, Mororó, Unha de Vaca, Bauínia, Pé de Boi, Brazilian Orchid Tree, Forked Bauhinia

## Overview

Bauhinia forficata, commonly called Pata de Vaca, contains the flavonoid kaempferitrin as its primary bioactive compound, which appears to exert hypoglycemic effects by mimicking insulin activity and enhancing peripheral glucose uptake. It is listed in the Brazilian National Pharmacopoeia and has been used in South American folk medicine as an antidiabetic and diuretic herb for over a century.

## Health Benefits

• Traditional use for diabetes management (evidence quality: traditional/preclinical only)
• [Antioxidant](/ingredients/condition/antioxidant) properties attributed to flavonoid content (evidence quality: preclinical only)
• Traditional diuretic effects for kidney support (evidence quality: traditional use only)
• Potential [anti-inflammatory](/ingredients/condition/inflammation) activity from terpenoid compounds (evidence quality: preclinical only)
• Possible anticoagulant properties noted in some Bauhinia species (evidence quality: preclinical only)

## Mechanism of Action

Kaempferitrin, the principal flavonoid glycoside in Bauhinia forficata leaf extracts, has been shown in preclinical models to stimulate glucose transporter GLUT4 translocation and inhibit intestinal alpha-glucosidase activity, slowing postprandial glucose absorption. Secondary flavonoids including quercetin-3,7-di-O-rhamnoside contribute to antioxidant activity by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and chelating transition metals, protecting pancreatic beta cells from oxidative stress. Aqueous leaf extracts also appear to modulate renal tubular reabsorption, which may partially explain the plant's traditional diuretic application.

## Clinical Summary

Human clinical evidence for Bauhinia forficata remains very limited; the bulk of supportive data comes from rodent studies using streptozotocin-induced diabetic models, where oral leaf decoctions at 200–400 mg/kg body weight produced statistically significant reductions in fasting [blood glucose](/ingredients/condition/weight-management). One small Brazilian pilot trial in type 2 diabetic patients reported modest fasting glucose reductions after 30 days of tea consumption, but the study lacked a placebo control and enrolled fewer than 30 participants. [Antioxidant](/ingredients/condition/antioxidant) effects have been demonstrated in vitro with DPPH radical scavenging IC50 values comparable to standard antioxidants, though translation to human outcomes has not been established. Overall, the evidence base is classified as traditional and preclinical, and no large randomized controlled trials have been completed to date.

## Nutritional Profile

Bauhinia forficata (Pata de Vaca) is a medicinal plant consumed primarily as a leaf tea/decoction rather than a dietary food source, so macronutrient intake from typical use is negligible. Key bioactive compounds identified in leaf material include: Flavonoids (primary active fraction) — kaempferitrin (kaempferol-3,7-dirhamnoside) is the predominant and most studied flavonoid, reported at approximately 1.5–3.2% dry weight of leaves; quercetin glycosides and isoquercitrin present at lower concentrations (~0.3–0.8% dry weight); kaempferol aglycone detected in hydrolyzed extracts. Alkaloids — small amounts of indole alkaloids reported in bark fractions; concentrations not well-quantified in published literature. Terpenoids — ursolic acid and oleanolic acid (pentacyclic triterpenes) identified in leaf wax fractions, estimated at 0.1–0.5% dry weight. Tannins — condensed and hydrolyzable tannins present at approximately 2–5% dry weight, contributing to astringency and [antioxidant](/ingredients/condition/antioxidant) capacity. Glycosides — sitosterol-glucoside and stigmasterol derivatives detected. Organic acids — succinic acid and other aliphatic acids present in aqueous extracts. Minerals (per 100g dry leaf, limited data): calcium (~800–1200 mg), potassium (~600–900 mg), magnesium (~150–250 mg), iron (~15–25 mg), zinc (~2–4 mg). Bioavailability notes: Kaempferitrin bioavailability is moderate; gut microbiota hydrolyze it to kaempferol aglycone, the likely active form systemically. Tannins may reduce mineral bioavailability when consumed as tea. Aqueous extraction (traditional decoction) captures flavonoids and tannins efficiently but extracts fewer lipophilic terpenoids compared to ethanolic preparations.

## Dosage & Preparation

No clinically studied dosage ranges are available as human clinical trials have not been reported. Traditional preparations involve leaf infusions without quantified dosing guidelines. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bauhinia forficata is generally well tolerated in traditional use at typical tea doses, but individuals taking oral hypoglycemic agents or insulin should use caution, as additive [blood glucose](/ingredients/condition/weight-management) lowering could increase hypoglycemia risk. Due to its diuretic properties, concurrent use with pharmaceutical diuretics or lithium may alter drug concentrations and should be medically supervised. Safety data in pregnant or breastfeeding women are absent, and use is not recommended during these periods. No standardized maximum dose has been established through clinical trials, and high-dose or prolonged supplementation has not been formally evaluated for hepatotoxic or nephrotoxic potential.

## Scientific Research

Despite traditional use, the research dossier reveals no specific human clinical trials, RCTs, or meta-analyses for Bauhinia forficata, with no PubMed PMIDs provided for such studies. WebMD notes its common use for diabetes but states there is no good scientific evidence supporting efficacy.

## Historical & Cultural Context

In Brazilian traditional medicine, Pata de Vaca leaves have been used for centuries as a tea or decoction primarily for diabetes, kidney issues, and as a diuretic. It holds an established place in South American folk herbalism, with historical records documented in pharmacognostic studies.

## Synergistic Combinations

Gymnema sylvestre, Cinnamon extract, Chromium picolinate, Alpha-lipoic acid, Bitter melon

## Frequently Asked Questions

### Does Bauhinia forficata lower blood sugar in humans?

Direct human clinical evidence is very limited, with only small, uncontrolled Brazilian pilot studies suggesting a trend toward fasting glucose reduction after 30 days of leaf tea consumption. The most robust data come from streptozotocin-diabetic rat models, where kaempferitrin-rich extracts at 200–400 mg/kg reduced blood glucose significantly. Patients with diabetes should not replace prescribed medications with Pata de Vaca without medical guidance.

### What is the active compound in Pata de Vaca?

The primary bioactive compound is kaempferitrin (kaempferol-3,7-di-O-alpha-L-rhamnoside), a flavonoid glycoside concentrated in the dried leaves of Bauhinia forficata. Secondary flavonoids such as quercetin-3,7-di-O-rhamnoside and flavonol glycosides also contribute to antioxidant and anti-inflammatory activity. These compounds collectively account for the plant's pharmacological profile documented in preclinical research.

### How is Bauhinia forficata traditionally prepared and dosed?

Traditionally, Pata de Vaca is prepared as a leaf decoction using approximately 1–2 grams of dried leaves per 150 mL of water, consumed two to three times daily in Brazilian folk medicine. The Brazilian National Pharmacopoeia recognizes the dried leaf as the medicinal part. No standardized clinical dose has been validated through controlled trials, so commercial supplement dosages vary widely and lack regulatory consensus.

### Can Bauhinia forficata interact with diabetes medications?

Yes, because kaempferitrin appears to enhance peripheral glucose uptake and inhibit alpha-glucosidase, combining Bauhinia forficata with metformin, sulfonylureas, or insulin carries a theoretical risk of additive hypoglycemia. Blood glucose should be monitored closely if use alongside antidiabetic drugs is considered. Consulting a healthcare provider before combining the herb with any prescription glucose-lowering therapy is strongly advised.

### Is Bauhinia forficata the same as Bauhinia variegata?

No, they are distinct species within the Bauhinia genus. Bauhinia forficata, native to South America, is the species documented in the Brazilian National Pharmacopoeia and studied for antidiabetic properties via kaempferitrin content. Bauhinia variegata, native to South and Southeast Asia, is used in Ayurvedic medicine for different indications and has a different phytochemical profile, so research findings from one species should not be assumed to apply to the other.

### Is Bauhinia forficata safe during pregnancy and breastfeeding?

There is insufficient clinical evidence to establish the safety of Bauhinia forficata during pregnancy and breastfeeding, and it should be avoided in these populations as a precautionary measure. Traditional use does not constitute proof of safety in vulnerable groups, and potential diuretic or anticoagulant effects could pose theoretical risks. Pregnant and nursing women should consult a healthcare provider before use.

### What is the difference between Bauhinia forficata leaf extract and whole leaf preparations?

Leaf extracts concentrate bioactive compounds like flavonoids and terpenoids, potentially providing higher potency per dose compared to whole leaf or tea preparations. However, the optimal form has not been definitively established through clinical research, as most evidence comes from preclinical and traditional use studies. The choice between extract and whole plant forms depends on individual preference and product standardization, as both are commercially available.

### What does the clinical evidence show about Bauhinia forficata's effectiveness compared to conventional diabetes treatments?

Clinical evidence in humans is limited; most research demonstrating blood sugar-lowering effects is preclinical or based on traditional use rather than randomized controlled trials. No clinical studies have directly compared Bauhinia forficata to standard diabetes medications in terms of efficacy or safety. The ingredient should be considered complementary rather than a replacement for evidence-based diabetes management without medical supervision.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*